Latest news for Haw Par Corp (OTC:HAWPF) Stock

Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

HAW PAR CORP LTD SG1 ORD by Haw Par Corp. Ltd.

Haw Par Corp Ltd

Haw Par Corporation (SG:H02) has released an update. Haw Par Corporation Limited has announced significant changes to its Board and Board Committee...

Haw Par Announces Board Restructuring

Haw Par (SG:H02) has released an update. Haw Par Corporation Limited conducted its 55th Annual General Meeting, emphasizing the legacy of the late ...

Haw Par Corporation Celebrates Legacy and Embraces Change

Haw Par Corp Ltd is a major drug manufacturing company that operates multiple brands. The company's primary strategy is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions.

Comments

Haw Par Corp

News

Latest news for Haw Par Corp (OTC:HAWPF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga